Neurodevelopmental disorders form a group of disabilities resulting from impairment of brain development and include syndromes such as Autism Spectrum Disorders (ASD), intellectual disability, Attention Deficit/Hyperactivity Disorder (AD/HD) and schizophrenia.
The etiology of neurodevelopmental disorders is complex as it involves a marked genetic contribution but probably also some environmental factors and/or a complex interaction between genes and environment [1] [2] [3] [4] . Despite strong heritability, less than 10% of syndromes such as ASD can be attributed to dominant mutations in a single gene 1 . Recent studies revealed a large array of rare, de novo mutations in ASD patients 5, 6 . Yet their biological significance remains elusive largely because, despite the predicted loss-offunction nature of some of these de novo mutations, the affected individuals are heterozygous carriers, suggesting that most of these candidate genes are either haploinsufficient and/or that these mutations lead to expression of dominant-interfering forms.
The complex network of interconnected neurons forming the human brain results from the coordinated activation of precise cellular processes such as neurogenesis, cell migration, axon guidance, dendrite patterning and synaptogenesis, culminating in formation of functional neural circuits. Despite the important morphological and functional differences between neurons, axon development can be operatively divided in three stages 7 : (1) axon specification, corresponding to the commitment of one neurite toward axonal fate, (2) axon elongation and guidance toward its target, and (3) branch formation, stabilization or elimination to form proper synaptic contacts. The cellular and molecular mechanisms underlying the establishment of neuronal connectivity have been extensively studied.
Extracellular factors such as axon guidance cues, neurotrophins and other growth factors convey information provided by the local environment that is relayed to intracellular signaling molecules to coordinate axon morphogenesis through the triggering of local cellular processes. One such signaling relay, the serine/threonine kinase LKB1, is involved 4 / 30 in several aspects of axonal development in the mouse cortex. Lkb1 is a tumor suppressor gene encoding a "master kinase" that activates a group of 14 downstream effectors forming a specific branch of the kinome and related to the metabolic regulator AMPK 8, 9 . LKB1 exerts sequential functions in neuronal development through the activation of at least two distinct sets of AMPK-related kinases (AMPK-RK): neuronal polarization and axon specification through the kinases BRSK1/2 (SAD-A/B) [10] [11] [12] , and axon elongation and terminal branching through NUAK1 (ARK5/OMPHK1) 13 . Furthermore the BRSK ortholog SAD-1 is involved in synapse formation in C. elegans 14, 15 whereas in the mouse cortex LKB1 has been shown to regulate synaptic transmission and neurotransmitter release through its ability to control mitochondrial Ca 2+ uptake 16 .
Several genes belonging to the AMPK-RK family came out of recent unbiased genetic screens for rare de novo mutations associated to neurodevelopmental disorders (Supplementary Table 1 ) [17] [18] [19] . Yet the functional consequences of these mutations and to what extent they contribute to the physiopathology of the disease remain unknown. To address this question, we focused on Nuak1, one of the AMPK-RK genes strongly expressed in the developing brain 13, 20 . Mutations in the Nuak1 genes have been linked to ASD 17, 21 , cognitive impairment 19 or AD/HD 22 . Interestingly the patients carrying these rare de novo mutations are by definition heterozygous carriers. Therefore, the actual contribution of these mutations to the disease mechanisms suggests that Nuak1 must be either haploinsufficient and/or the mutated allele must be exerting a dominant-negative influence over the wild-type allele.
In this study we present evidence demonstrating that the inactivation of one allele of the Nuak1 gene results in a complex phenotype including growth retardation, defective axonal mitochondria trafficking and decreased terminal axon branching of cortico-cortical projections. We reveal that Nuak1 heterozygosity disrupts long-term memory consolidation, alters the preference for social novelty without affecting conspecific social preference, and decreases the prepulse inhibition (PPI) of the acoustic startle reflex. Finally we adopted a gene-replacement strategy to further characterize the functional consequence of Nuak1 rare de novo mutation identified in ASD patients. Overall, our results indicate that Nuak1 is haploinsufficient for the development of cortical connectivity and support the hypothesis that mutation in Nuak1 participates in the etiology of neurodevelopmental disorders.
RESULTS

NUAK1 haploinsufficiency impairs mouse cortical development
We first mapped the temporal and spatial pattern of expression of Nuak1 in the developing and adult mouse brain using in situ hybridization. This revealed that Nuak1 mRNA is highly expressed in the developing and adult mouse brain, with specific expression in the neocortex, pyriform cortex, hippocampus and cerebellum (granule cells but not Purkinje cells). In contrast, Nuak1 expression was low or absent in the dorsal thalamus and striatum ( Fig. S1A-I ). Western-blot analyses from mouse brain extracts confirmed that NUAK1 protein is expressed at high level in the developing and adult cortex. In the hippocampus, NUAK1 expression was maintained throughout all developmental stages, although it decreased with age ( Fig. S1J) .
Constitutive knockout (KO) of Nuak1 is lethal in the late embryonic/perinatal period in mice due to an abdominal midline closure defect called omphalocoele 20 . Despite strong expression in the embryonic brain, the initial characterization of Nuak1 KO embryos did not reveal any obvious morphological brain defect 20 . Accordingly, we did not observe any difference between wild-type (WT), heterozygous (HET) and KO embryos in axonal markers (SMI312) or cortical lamination (TBR1: layer 6, and CTIP2: layer 5), indicating no major abnormalities in neuronal polarization, axon tract formation, neurogenesis, neuronal migration and lamination ( Fig. S2A-F) . We observed a marked decrease (~50%) of NUAK1 protein level in HET neurons (Fig. 1A) , suggesting that the remaining allele does not 6 / 30 compensate for the loss of one copy of Nuak1. Unlike the homozygotes constitutive knockout (NUAK1 -/-), heterozygous mice (NUAK1 +/-) are viable and fertile and do not display the omphalocoele phenotype. Quantitative analysis revealed a moderate but significant growth retardation in NUAK1 +/-compared to WT littermates (Fig. 1B-C) , more pronounced in males than females.
We performed histochemical analyses of NUAK1 +/-mouse brains at Postnatal day (P)21
(weaning) or P40 (young adult). The global organization of the brain appeared largely normal, with a normal segregation of somatodendritic and axonal markers (Supplementary (Fig. 1F) , which was accompanied by a corresponding thinning of the cortex along its radial axis (Fig. 1G) , whereas the volume of two other brain structures (the striatum and hippocampus) was not affected (Fig. 1H-I ).
Overall, our data suggest that although NUAK1 +/-mice are viable, Nuak1 is haploinsufficient regarding brain development.
NUAK1 exerts a dose-dependent role in cortical axon development
We previously characterized that NUAK1 is necessary and sufficient for terminal axon branching of layer 2/3 cortical neurons through the presynaptic capture of mitochondria 13 .
In order to determine if these phenotypes are also observed upon loss of one copy of Nuak1, we first performed neuronal cultures following ex utero cortical electroporation (EUCE) of WT, NUAK1 +/-and NUAK1 -/-embryos at E15.5. We observed a reduction of axon length and branching in NUAK1 +/-and NUAK1 -/-neurons when compared to WT neurons ( Fig. 2A-C) . Time-lapse imaging of mitochondria trafficking in developing layer 2/3 cortical axons revealed that mitochondria motility is markedly increased in the anterograde and retrograde direction for both NUAK1 +/-and NUAK1 -/-neurons compared to control WT neurons ( Fig. 2D-F) . Quantifications confirmed that NUAK1 exerts a dose-dependent effect on axon development and that HET neurons have a significant reduction in both maximum axon length and the number of collateral branches (Fig. 2G-I) . We also quantified the fraction of stationary mitochondria and observed a marked reduction in the percentage of stationary mitochondria per axon in NUAK1 +/-and NUAK1 -/-neurons compared to control WT neurons (Fig. 2J) .
We subsequently turned to long-term in utero cortical electroporation (IUCE) to determine the consequences of Nuak1 heterozygosity on terminal axon branching in vivo. We targeted pyramidal neurons of the superficial layers 2/3 of the primary somatosensory cortex (S1) through IUCE of a mVenus coding plasmid at E15.5 in WT (NUAK1
) and HET (NUAK1 +/-) embryos. Mice were sacrificed at Postnatal day (P)21, a stage when terminal branching of these cortico-cortical projecting (callosal) axons is adult-like 23, 24 . The loss of one copy of Nuak1 had no effect on neurogenesis, radial migration and axon formation (Fig. 2K-L) .
Furthermore, callosal axons crossed the midline and reached the contralateral hemisphere.
However we observed a marked decrease in terminal branching on the contralateral hemisphere in NUAK1 +/-mice compared to WT littermates ( Fig. 2M-N) . Interestingly, axon branching on the ipsilateral hemisphere was largely unaffected ( Fig. 2O-P) . A similar phenotype was observed in older mice (P90) mice (Fig. S3) , indicating that this deficit in terminal axon branching does not result from a simple delay in axon development and persists in adulthood.
NUAK1 heterozygosity disrupts long-term memory consolidation
Despite being involved in cortical axon morphogenesis (present study and 13 ), the functional consequences of Nuak1 heterozygosity are largely unknown. In order to investigate the effect of NUAK1 haploinsufficiency on mouse behavior, we generated age-matched cohorts of WT and NUAK1 +/-mice and performed a battery of behavioral assays relevant to neurodevelopmental disorders. Control experiments demonstrated that vision and olfaction
were not impaired in NUAK1 +/-mice, as demonstrated by tracking of head movement using an optomotor test (Fig. S4A) and by the habituation/dishabituation to novel odor test (Fig.   S4B ). Furthermore NUAK1 +/-mice exhibited no difference in spontaneous locomotor activity and exploratory behavior in the Open Field (Fig. S5A-C ).
Next, we tested how NUAK1 heterozygosity affects memory formation and consolidation through two distinct cognitive paradigms: first, we investigated non-spatial memory using the Novel Object Recognition (NOR) task 25 ( Fig. 3A) . Fig. 3B-C ). Second, we tested spatial memory formation and maintenance using the Barnes Maze assay 26 ( Fig. 3C ). While this test is similar to the Morris Water Maze in probing spatial memory, it is less physically taxing and does not induce stress/anxiety response linked to swimming in water 27 . There were no significant differences involving sex or genotype in the acquisition of escape behavior. In the probe trial both WT and NUAK1 +/-mice showed a clear preference for the target quadrant relative to other quadrants ( 
NUAK1 heterozygosity impairs novelty preference and sensory gating
We next performed a series of behavioral assays relevant to autistic-like traits. We observed spontaneous activity through Open Field sessions ( Fig. S5A-F ) but did not detect any differences between WT and NUAK1 +/-mice in behaviors classically associated with anxiety or repetitive behavior.
Social interactions were assessed using the 3-chamber sociability assay (Fig. 4A ) 28 . There was no overall genotype difference, but a significant overall effect of time in chamber choice between another mouse and an inanimate object, indicating that conspecific sociability is not affected by NUAK1 heterozygosity. In a second test, we assessed the preference of NUAK1 +/-mice for social novelty (Fig. 4D) . In this case, there were overall effects of chamber and contact times, but also significant interactions between these factors and genotype (F's -3.7-5.1, p<0.05). WT mice spent more time in the chamber with the novel mouse and interacted more with the novel individual. However, NUAK1 +/-mice displayed no preference between the familiar and the novel mouse ( Fig. 4E-F ). Importantly this effect was not due to a lack of interest for novelty since NUAK1 +/-mice showed a preference for a novel object similar to their WT littermates in the Novel Object Recognition (NOR) task 25 ( Fig. 3A-C) . Altogether, our results point to a deficit in the preference for social novelty upon loss of one copy of Nuak1.
We subsequently investigated sensorimotor gating through prepulse inhibition (PPI) of the startle response induced by weaker prestimuli 29, 30 ( Interestingly, there was a significant startle sound level x genotype x sex interaction (F(7,308)=2.09, p<0.05), revealing a more pronounced increase in NUAK1+/-males compared to NUAK1+/-females ( Fig. S6B-C stronger effect in males than in females ( Fig. S6B-C) . We retested the mice by submitting NUAK1 +/-to a milder tone in order to normalize the intensity of the startle response between WT and NUAK1 +/-animals. Under these conditions, we observed a milder, and nonsignificant PPI reduction in NUAK1 +/-males and no differences in NUAK1 +/-females compared to control WT littermates ( Fig. S6D-E , see figure legend for statistical results).
Finally, we observed that the optimal InterStimulus Interval (ISI) was similar between WT and NUAK1 +/-mice, and that the PPI was impaired at all ISI examined, indicating that the deficit in PPI does not result from an abnormality in the temporal function of the startle reflex (Fig. S6A) . Taken together, our results indicate that NUAK1 heterozygosity induces a deficit in the PPI reflex that is likely due to a strong increase in the initial startle response.
NUAK1 cell-autonomously control axon branching
Given the embryonic lethality characterizing the NUAK1 -/-constitutive knockout, we generated a conditional floxed Nuak1 mouse model (NUAK1 F allele) ( Fig. S7A-B ) allele of Nuak1 showed again a dose-dependent effect on axon growth and branching ( Fig. S7C-H) , thus validating the conditional allele as a potent loss-of-function mutation phenocopying the constitutive allele.
Next, we performed long-term IUCE of plasmids encoding Cre recombinase in floxed NUAK1 embryos at E15.5 to quantify axon branching of layer 2/3 pyramidal neurons in vivo at P21. Importantly, this approach is also testing the cell-autonomy of NUAK1 deletion since
Cre-expressing neurons are relatively sparse (~10% of all layer 2/3 neurons) and their axons grow in a largely wild-type environment. Similarly to our observations in NUAK1 +/-mice, Nuak1 conditional deletion had no effect on neurogenesis, radial migration, axon formation and ipsilateral branching (Fig. 5A-C and 5G) . However, we observed a marked decrease of contralateral axon branching of layer 2/3 neurons upon inactivation of one or both alleles (Fig. 5D-F and 5H) , strongly arguing that Nuak1 is haploinsufficient with regard to the establishment of cortico-cortical connectivity during postnatal development.
Finally in order to determine the consequence of a complete deletion of NUAK1 on mouse behavior, we crossed NUAK1 F/F mice with NEX CRE mice to drive CRE recombinase expression specifically in neural progenitors of the dorsal telencephalon 31 ( Fig. 6A) .
Conditional inactivation of one (cHET) or both (cKO) copies of Nuak1 had no effect on mouse viability and postnatal growth ( Fig. 6A and S8A) . We then performed the NOR task and the three-chambered social preference and social novelty assay on age matched cohorts of WT, cHET and cKO animals. As was the case upon constitutive deletion of NUAK1, there was no overall effect of genotype on novel object recognition ( Fig. S8B ) and conspecific sociability as measured by time in chamber (Fig. 6B ) and direct contact times (Fig. S8C) . However during the social novelty phase of the assay, NUAK1 cHET and NUAK1 cKO mice showed a lack of preference for the novel mouse compared to the familiar mouse as measured by time in chamber (Fig. 6C ) and direct contact times (Fig.   S8D ). Taken together our results indicate that the partial or complete inactivation of Nuak1 in the dorsal telencephalon disrupts the preference for social novelty in the mouse and confirms that NUAK1 is haploinsufficient for mouse social behavior.
Functional analysis of NUAK1 mutation associated with ASD
Finally, we tested whether NUAK1 mutations identified in autistic patients affect the function of the protein. The de novo mutation most frequently identified in genetic studies and with the highest confidence score is a nonsense mutation inducing a Premature Termination Codon (PTC) corresponding to Glutamine 433 (mouse 434) of the protein (Fig. 7A and Supplementary Table 1) . Notably this PTC occurs in the long, last coding exon of Nuak1 (Fig. S7A) and thus is not predicted to be subjected to nonsense mediated decay 32 . The mutation (hereafter named NUAK1 STOP) predictably leads to the truncation of a large portion of the C-terminal extremity (CTD) of the protein, and removes one activating AKTphosphorylation site as well as two GILK motifs required for the interaction with the myosin phosphatase complex 33 .
We used site-directed mutagenesis to introduce the PTC mutation in NUAK1 coding plasmids, creating an expression vector encoding NUAK1 STOP, and used this construct to determine the consequences of NUAK1 protein truncation. We observed by Western-blot that the mutation had no impact on the expression of the protein (Fig 7B) , suggesting that the removal of a large portion of NUAK1 CTD is unlikely to reduce protein stability.
We then investigated the consequences of expression of NUAK1 STOP protein on axon growth and branching. To reach that goal, we adopted a gene-replacement strategy to express either WT or mutant NUAK1 STOP protein in NUAK1-null neurons. We performed EUCE in NUAK1 F/F embryos at E15.5 and determined axon morphology at 5DIV. As reported above upon the inactivation of NUAK1 expression through Cre recombinase expression, neurons had shorter axons with reduced branching (Fig. 7C-D) . Re-expression of WT NUAK1 protein fully rescued axon length and axon branching (Fig. 7E) . On the contrary two mutants, a kinase dead (KD) mutant that totally abolishes NUAK1 catalytic activity, and a mutant of the LKB1-activation site (TA), failed to rescue the axonal phenotype ( Fig. 7F-G) confirming that NUAK1 function in axon morphogenesis is kinasedependent. Interestingly, NUAK1 STOP mutant could rescue axon elongation to the same extent as the WT NUAK1, but was not able to rescue collateral branch formation (Fig. 7H and L-M).
/ 30
Finally we investigated whether the NUAK1 STOP mutation acts as a dominant negative (DN). We expressed either WT or mutant forms of NUAK1 into WT neurons (NUAK1 F/F without Cre) by EUCE and observed axon morphology at 5DIV. As observed previously 13 , overexpression of WT NUAK1 was sufficient to increase axon branching (Fig. 7I) . In contrast, neurons expressing the NUAK1 STOP mutant protein had limited to no effect on axon length or branching (Fig. 7J) . Quantification of axon morphology confirmed that NUAK1 STOP mutant failed to increase branching (Fig. 7K-M) . We only observed a moderate reduction in collateral branch formation upon expression of the NUAK1 STOP mutant, indicating that NUAK1 truncation has only a moderate inhibitory activity over endogenous NUAK1 and behaves mostly as a loss-of-function.
DISCUSSION
In the present study, we characterized for the first time the consequences of Nuak1 , the clinical manifestations of PJS do not typically include neurological manifestations 37 . As it is the case for many tumor suppressor genes for which a two hit inactivation of genes is required for cell transformation, it is worth noting that LKB1 is expressed to almost normal levels in LKB1 +/-mice contrary to NUAK1 protein which is reduced by roughly 50% in NUAK1 +/-constitutive knockout mice. Catalytic activity and subcellular localization of LKB1 is dependent upon the formation of a heterotrimeric complex with the pseudokinase STRAD and the adaptor protein Mo25 40, 41 . Interestingly genetic inactivation of STRADα (also called LYK5), one of the two isoforms of the STRAD pseudokinase, cause a rare neurodevelopmental syndrome termed PMSE (Polyhydramnios, Megalencephaly and Symptomatic Epilepsy) 42, 43 . Furthermore STRADα plays a dominant but partially redundant role over STRADβ in axon development 44 .
Therefore Lkb1 might be indirectly linked to disorders of neurodevelopment through subtle alterations of the function of the LKB1 complex.
In this study, we adopted a gene-replacement strategy to determine the functional relevance of one of the de novo mutations in the Nuak1 gene potentially to ASD in human 17 and leading to the expression of a truncated protein. indeed we did not observe any marked dominant-negative effect upon NUAK1 STOP overexpression in WT cortical neurons, which would be the expected outcome from a gain of an aberrant function. Interestingly the NUAK1 protein has a long C-terminal tail containing potential regulatory sites including an AKT phosphorylation site 45 and three short GILK motifs promoting NUAK1 interaction with Protein Phosphatase 1β (PP1β) 33 . LKB1
activation is achieved through nuclear export and cytosolic capture within the STRAD/Mo25 complex 40, 41 . Similarly it is plausible that NUAK1 activity and subcellular localization depend upon protein-protein interactions through the C-terminal domain of the protein.
The behavioral alterations in NUAK1 +/-mice are largely consistent with the identification of rare de novo Nuak1 mutations in autistic patients 17, 21 . Indeed NUAK1 +/-mice display some features associated with the autistic clinical spectrum, including disruption of social novelty preference, moderate cognitive deficits, and a reduction in the PPI reflex. However, other behavioral alterations typical of ASD were absent in NUAK1 +/-mice. In particular, we did not detect any stereotyped or repetitive behavior in heterozygous mice, nor an effect on general sociability. In humans, the large heterogeneity in the clinical manifestations of syndromes falling in the autistic spectrum partially overlaps clinical manifestations associated with psychiatric disorders such as schizophrenia 46, 47 . Importantly most behavioral alterations we report here are equally indicative of ASD, intellectual disability and schizophrenia-like disease. Of note the activity of NUAK1 +/-mice was largely normal despite reports linking Nuak1 mutations and AD/HD 22 . One important distinction between ASD and schizophrenia is the age of the onset of phenotype, schizophrenia being typically diagnosed at adolescence or in young adults following a rather asymptomatic prodromal phase, whereas autism is typically detected in young children. The most commonly used behavioral tests relevant to ASD or schizophrenia in the mouse are performed in young adults. Yet it is worth noting that terminal axon branching defects can be detected as early as P21 in NUAK1 +/-mice, suggesting that some phenotypic alterations might be present before or around weaning. Importantly we also observed that the branching deficit persisted or even increased up to stage P90, corresponding to the age at which we assessed mouse behavior.
Many neurodevelopmental disorders have a strong sex bias. For instance ASD affects more frequently young males than females 48 . Furthermore, schizophrenia displays some subtle differences in its incidence and clinical manifestations between male and female patients 49 .
The majority of the alterations we identified in NUAK1 +/-mice were similar in males and females, for example the reduction in terminal axon branching. However growth retardation was especially marked in NUAK1 +/-males, as was the increased startle response and decreased PPI reflex. The relevance of these findings for human pathology is currently unknown.
Gene-network analyses of genes linked to ASD or schizophrenia identified clusters of candidate genes involved in synapse formation, protein synthesis and RNA translation, signaling pathways, gene regulation and chromatin remodeling [50] [51] [52] [53] . This evidence points toward synaptic function and plasticity as key processes in the physiopathology of neurodevelopmental disorders. In line with that observation, a significant part of the clinical manifestation can be reversed after the development period, suggesting that synaptic plasticity plays an important role in the disease 54 . Yet in parallel there is ample evidence that ASD and schizophrenia have a strong developmental component and that clinical manifestations may arise from early insults to neural circuits formation. The main consequence of NUAK1 heterozygosity is a reduction in terminal cortical axon branching, suggesting a direct link between axonal development and neurodevelopmental manifestations. Interestingly a similar reduction in terminal axon branching has been recently observed in a mouse model for the 22q11.2 deletion, strongly associated to schizophrenia 55 . Our work strengthens the link between a disruption of cortical connectivity and disruption in cognitive and social behavior in the mouse and warrants further studies of axon development in the pathophysiology of neurodevelopmental disorders.
A recent study showed that NUAK1 mediates the phosphorylation of the microtubule associated protein TAU on S356 and might be involved in tauopathies such as Alzheimer's disease (Lasagna-Reeves et al., 2016). These results suggest that NUAK1 over-activation might lead to neurodegeneration. In the present study, we have only examined the role of NUAK1 loss-of-function during embryonic and early postnatal development, but since its expression is maintained in the adult brain, future experiments should address NUAK1 function in adult circuits maintenance.
As a whole, we gathered evidence that expression of the autism-linked Nuak1 Q433-Stop mutation disrupts cortical axon branching in vivo. Coupled with our observation that Nuak1 heterozygosity impairs brain development, cortical axon branching in vivo, and that NUAK1 +/-mice have cognitive and social novelty defects strongly argues that Nuak1 lossof-function mutations could be causally linked to neurodevelopmental disorders in humans and support targeted efforts to identify additional genetic alterations in the Nuak1 gene.
Future experiments will need to determine if other rare de novo loss-of-function mutations identified in genes such as Nuak1 are also haploinsufficient with regard to development of brain connectivity and if this is a general genetic mechanism underlying a fraction of neurodevelopmental and/or neuropsychiatric disorders. 
MATERIALS AND METHODS
Animals
Image Acquisition and Analyses
Confocal images were acquired in 1024x1024 mode with a Nikon Ti-E microscope equipped with the C2 ( Supplementary Fig 2 and Fig 7) or the A1R (all others) laser scanning confocal microscope using the Nikon software NIS-Elements (Nikon). We used 
Behavior analyses
Two groups of age-related NUAK1 HET mice and WT littermates were submitted to behavioral assays in the Mouse Behavioral Assessment Core at The Scripps Research
Institute in San Diego, CA. All quantifications were performed by experienced technicians blind to genotype. Mice were between age 10 and 12 weeks at the start of testing.
Procedure, quantification method, order of experiments and group constitution is detailed in the Extended Material and Methods.
DNA, Plasmids and cloning
The empty vector pCAG-IRES-GFP (pCIG2), CRE expressing vector pCIG2-CRE 56 , mVENUS expressing vector pSCV2 57 , and mitochondria-tagged DsRed expressing pCAG-mitoDsRED 13 Neuronal expressing vectors for NUAK1 (pCIG2-Flag-mNUAK1) were obtained by inserting wild-type and mutant NUAK1 cDNA into a pCIG2 vector between XhoI and EcoRI sites.
Western blotting
Western blotting was carried out as previously published 58 . Cells and tissues were lysed in ice-cold lysis buffer containing 25 mM Tris (pH7.5), 2 mM MgCl2, 600 mM NaCl, 2 mM EDTA, 0.5% Nonidet P-40, and 1× protease and phosphatase mixture inhibitors (Roche).
20
μ g aliquots of lysate were separated by electrophoresis on a 10% SDS-polyacrylamide gel and transferred on a polyvinylidene difluoride (PVDF) membrane (Amersham).
Incubation with primary antibody was performed overnight in 5% milk-TBS-Tween. The next day, membranes were incubated at room temperature for 1 hour with HRP-linked secondary antibodies. Western-blot revelation was performed using ECL (Amersham).
Imaging and analysis were performed on a chemidoc imager (Bio-rad) using the ImageQuant software.
Ex Vivo Cortical Electroporation
Electroporation of dorsal telencephalic progenitors was performed as described previously 59 . A mix containing 1 μ g/μl endotoxin-free plasmid DNA (Midi-prep kit from MachereyNagel) plus 0.5% Fast Green (Sigma; 1:20 ratio) was microinjected in lateral ventricles of the brain of E15.5 embryos using the MicroInject-1000 (BTX) microinjector.
Electroporations were performed on the whole head (skin and skull intact) with gold-coated electrodes (GenePads 5 × 7 mm BTX) using an ECM 830 electroporator (BTX) and the following parameters: Five 100 ms long pulses separated by 100 ms long intervals at 20 V.
Immediately after electroporation, the brain was extracted and prepared as stated in the neuronal culture section below.
Primary neuronal culture
Cortices from E15.5 mouse embryos were dissected in Hank's Buffered Salt Solution 
Statistical Analyses
Sample size is detailed in the figures. Statistical tests were performed using Prism 
